| Gene symbol | IL2 | Synonyms | IL-2, TCGF, lymphokine | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q27 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 2 | ||||
| Gene symbol | XCL1 | Synonyms | ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1, SCM1A, SCYC1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q24.2 | dbXrefs | |
| Description | X-C motif chemokine ligand 1 | ||||
| GTO ID | GTC1207 |
| Trial ID | NCT00062855 |
| Disease | Neuroblastoma |
| Altered gene | XCL1|IL-2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | XCL1/IL-2 Ad Neuroblastoma cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Study of Chemokine and Cytokine Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector (CYCHE) |
| Year | 2003 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H6442|Cyche |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||